✦ LIBER ✦

Vinorelbine (VB)+ cisplatin (DDP)+ etoposide (E) in the treatment of non-operable non small cell lung cancer (NSCLC)

✍ Scribed by Marangolo, M.; Intini, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase study: Mavelbine (N) + etoposide (

✍ Richardet, E.; Lazaris, C.; Uribe, A.; Carranza, L.; Cresta, C.; Tolocka, H.; Ca 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Ifosfamide (IFO)+vinorelbine (VRL) as tr

✍ Pawel, J.v.; Schroeder, M.; Grole-Kiehn, J.; Kerpel-Fronius, S.; Tresca, P.; Wes 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Vinorelbine (VNB) + ifosfamide (IFX) in

✍ Rivero, O.; Lozano, M.; Polera, J.; Matiewjuk, M.; Bonicatto, S.; Callejas, C.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Taxol and cisplatin (TP) versus etoposid

✍ T.E. Ciuleanu; C. Cebotaru; I. Radulescu; N. Todor; N. Ghilezan 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Vinorelbine (NVB) versus vinorelbine plu

✍ Depierre, A.; Chaslang, C.; Quoix, E.; Blanchon, F.; Lebeau, B.; Besenval, M.; P 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Cisplatin, etoposide and mitomycin (CVM)

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 143 KB